We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quantum Phar. | LSE:QP. | London | Ordinary Share | GB00BRTL8Q42 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.2374 | 84.00 | 84.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMQP.
RNS Number : 1382P
Quantum Pharma PLC
14 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer QUANTUM PHARMA PLC or the underlying issuer of existing shares to which voting rights are attached: ----------------------------- ------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------- An acquisition or disposal of voting rights Yes ---------------------------------------------- ---- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------- ---- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------- ---- An event changing the breakdown of voting rights ---------------------------------------------- ---- Other (please specify): -------------------------------------------- ---- 3. Full name of person(s) subject to the notification Harwood Capital LLP obligation: (as investment adviser/manager) and North Atlantic Smaller Companies Investment Trust plc --------------------------------- ---------------------------------- 4. Full name of shareholder(s) (if different from 3.): 1. North Atlantic Smaller Companies Investment Trust PLC 2. Oryx International Growth Fund Limited --------------------------------- ---------------------------------- 5. Date of the transaction 11 NOVEMBER 2016 and date on which the threshold is crossed or reached: --------------------------------- ---------------------------------- 6. Date on which issuer 14 NOVEMBER 2016 notified: --------------------------------- ---------------------------------- 7. Threshold(s) that is/are crossed or reached: ABOVE 14% --------------------------------- ---------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------- Class/type Situation Resulting situation after of previous the triggering transaction shares to the triggering transaction if possible using the ISIN CODE -------------- ---------------------------- ------------------------------------------------------------ Number Number Number Number of % of voting of of of voting rights Shares Voting shares rights Rights -------------- ------------- ------------- ------------- ------------------------ ------------------- Direct Direct Indirect Direct Indirect -------------- ------------- ------------- ------------- ------------- --------- -------- --------- Holder 1: 3,921,158 3,921,158 10,000,000 10,000,000 5.91% Holder 2: 10,000,000 10,000,000 15,000,000 15,000,000 8.87% -------------- ------------- ------------- ------------- ------------- --------- -------- --------- B: Qualifying Financial Instruments -------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of % of voting instrument date Conversion voting rights Period rights that may be acquired if the instrument is exercised/ converted. ------------------ ----------- ------------ ------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of % of voting financial price date Conversion voting rights instrument period rights instrument refers to ------------ --------- ----------- ------------ ------------ ---------------- Nominal Delta ------------ --------- ----------- ------------ ------------ -------- ------ Total (A+B+C) ----------------------------------------------- Number of voting rights Percentage of voting rights ------------------------ --------------------- 25,000,000 14.78% ------------------------ --------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ------------------------------------------------------------ Proxy Voting: -------------------------------- 10. Name of the proxy holder: ------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------ 13. Additional information: ------------------------------- -------------- 14. Contact name: Jane Muir ------------------------------- -------------- 15. Contact telephone number: 020 8819 6486 ------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGAGGUPQGQC
(END) Dow Jones Newswires
November 14, 2016 11:20 ET (16:20 GMT)
1 Year Quantum Phar. Chart |
1 Month Quantum Phar. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions